Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.

Last updated: January 16, 2024
Sponsor: King Edward Medical University
Overall Status: Completed

Phase

2/3

Condition

Hyponatremia

Skin Wounds

Treatment

5% Albumin (human) Solution

Paeds solution

Clinical Study ID

NCT06224777
260/RC/KEMU
  • Ages 1-12
  • All Genders

Study Summary

The goal of this comparative, interventional randomized controlled trial is to use albumin during resuscitation in pediatric burn patients on day 2, as it can reduce extravasation of fluids and decrease the overall fluid requirements, along with mortality and maintain circulation.

Participants will be divided into 2 groups. Albumin will be administered additionally in group A, while only crystalloids will be used for resuscitation in group B.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 25-40%, less than 12 hours old, scald or flame burn patients
  • Full thickness

Exclusion

Exclusion Criteria:

  • Burns with inhalational injury.
  • Patients hypersensitive to Albumin.
  • Deranged renal or hepatic profile.
  • Patients with known Cardiac or debilitating Congenital anomalies.
  • Patients with known metabolic disease.
  • Burns associated with trauma including fractures, head injuries, intra-abdominal bleedetc.
  • Albumin level lower than 1.8g/dl at time of admission.

Study Design

Total Participants: 90
Treatment Group(s): 2
Primary Treatment: 5% Albumin (human) Solution
Phase: 2/3
Study Start date:
January 01, 2022
Estimated Completion Date:
May 17, 2023

Study Description

The randomized controlled trial will be done at Department of Pediatric Surgery, Mayo Hospital Lahore from January 2022 to December 2022. Ninety patients (forty-five patients in each group) will be enrolled using a non probability convenient sampling technique. Patients will be randomly divided into 2 groups. Albumin solution will be administered in group A and in group B only routine crystalloids will be given. Basic demographic information will be noted. Effect modifiers (hemoglobin, Albumin level, weight and height) will be noted.

Group A: After first 24 hours, maintenance fluid, N/2+5%Dextrose solution will be started according to weight(100ml/kg/day for first 10kg, 50ml/kg/day for next 10kg and 20ml/kg/day for the remainder) and will be increased or decreased by 1/3 to maintain the urinary output to 1-1.5ml/kg/hour. 12, 75 5% Albumin solution will be administered @0.5ml/kg/%burn over initial 8 hours of day 2 and It's amount will be subtracted from the 24 hours fluid calculated earlier.

Group B: After first 24 hours, maintenance fluid, N/2+5%Dextrose solution will be started according to weight (100ml/kg/day for first 10kg, 50ml/kg/day for next 10kg and 20ml/kg/day for the remainder) and will be increased or decreased by 1/3 to maintain the urinary output to 1-1.5ml/kg/hour.

Connect with a study center

  • King Edward Medical University, Mayo Hospital

    Lahore, Punjab 54000
    Pakistan

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.